Familial thrombophilia and lifetime risk of venous thrombosis
暂无分享,去创建一个
F R Rosendaal | F E Preston | F. Rosendaal | G. Palareti | M. Makris | J. Fontcuberta | J. Souto | I. Pabinger | F. V. D. van der Meer | I. Scharrer | P. Svensson | I. Walker | M Makris | I D Walker | G Palareti | J. Conard | I Pabinger | J C Souto | J Conard | C Y Vossen | J Fontcuberta | I Scharrer | P Svensson | F J M Van Der Meer | C. Y. Vossen | F. Preston | I. Pabinger | F. Meer | C. Y. Vossen
[1] Pieter H. Reitsma,et al. Mutation in blood coagulation factor V associated with resistance to activated protein C , 1994, Nature.
[2] J. Miletich. Thrombophilia as a multigenic disorder. , 1998, Seminars in thrombosis and hemostasis.
[3] B. Dahlbäck,et al. Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S. , 1995, Blood.
[4] P. Reitsma,et al. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. , 1996, Blood.
[5] F. Rosendaal. Venous thrombosis: a multicausal disease , 1999, The Lancet.
[6] B. Lindblad,et al. A prospective study of the incidence of deep‐vein thrombosis within a defined urban population , 1992, Journal of internal medicine.
[7] P. Reitsma,et al. Apparent different thrombotic tendency in patients with factor V Leiden and protein C deficiency due to selection of patients. , 1996, Blood.
[8] J. Vandenbroucke,et al. Mortality and causes of death in families with the factor V Leiden mutation (resistance to activated protein C). , 1997, Blood.
[9] T. Barbui,et al. Different Incidence of Venous Thrombosis in Patients with Inherited Deficiencies of Antithrombin III, Protein C and Protein S , 1994, Thrombosis and Haemostasis.
[10] P. Reitsma,et al. Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families. , 1994, Blood.
[11] M. Prins,et al. Incidence of Venous Thromboembolism in Families with Inherited Thrombophilia , 1999, Thrombosis and Haemostasis.
[12] G. Leone,et al. Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families. , 1998, Blood.
[13] J. Vandenbroucke,et al. Venous Thrombotic Risk in Family Members of Unselected Individuals with Factor V Leiden , 2000, Thrombosis and Haemostasis.
[14] D. Hommes,et al. Mortality in hereditary antithrombin-III deficiency—1830 to 1989 , 1991, The Lancet.
[15] J. Vandenbroucke,et al. Survival in families with hereditary protein C deficiency, 1820 to 1993 , 1995, BMJ.
[16] P. Reitsma,et al. Factor V Leiden (FV R506Q) in Families with Inherited Antithrombin Deficiency , 1996, Thrombosis and Haemostasis.
[17] C. Esmon,et al. Familial protein S deficiency is associated with recurrent thrombosis. , 1984, The Journal of clinical investigation.
[18] J. Griffin,et al. Deficiency of protein C in congenital thrombotic disease. , 1981, The Journal of clinical investigation.
[19] Paolo Prandoni,et al. The Long-Term Clinical Course of Acute Deep Venous Thrombosis , 1996, Annals of Internal Medicine.
[20] T. Barbui,et al. Clinical Manifestations and Management of Inherited Thrombophilia: Retrospective Analysis and Follow-up after Diagnosis of 238 Patients with Congenital Deficiency of Antithrombin III, Protein C, Protein S , 1994, Thrombosis and Haemostasis.
[21] P. Callas,et al. The clinical spectrum of heterozygous protein C deficiency in a large New England kindred. , 1989, Blood.
[22] F. Rosendaal. Risk factors for venous thrombosis: prevalence, risk, and interaction. , 1997, Seminars in hematology.
[23] D. Hosmer,et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. , 1991, Archives of internal medicine.
[24] L. Melton,et al. Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. , 1999, Archives of internal medicine.
[25] P. Reitsma,et al. Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study) , 1995, Blood.
[26] J. Vandenbroucke,et al. Gene-gene and gene-environment interactions determine risk of thrombosis in families with inherited antithrombin deficiency. , 1999, Blood.
[27] O. Egeberg. Inherited Antithrombin Deficiency Causing Thrombophilia , 1965, Thrombosis and Haemostasis.
[28] P. Mannucci,et al. Risk of venous thromboembolism and clinical manifestations in carriers of antithrombin, protein C, protein S deficiency, or activated protein C resistance: a multicenter collaborative family study. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[29] I. Peake. International Society on Thrombosis and Haemostasis , 1974, Thrombosis and Haemostasis.
[30] P. Mannucci,et al. Inherited Thrombophilia: Part 1 , 1996, Thrombosis and Haemostasis.
[31] H. Büller,et al. Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis , 1997, The Lancet.
[32] P. Mannucci,et al. Inherited Thrombophilia*: Part 2 , 1996, Thrombosis and Haemostasis.